Questran Light

Hardening of the Arteries, partial biliary obstruction, Itching + 1 more
Treatment
5 FDA approvals
20 Active Studies for Questran Light

What is Questran Light

CholestyramineThe Generic name of this drug
Treatment SummaryCholestyramine is a medication that helps your body get rid of bile acid. It is a type of polymeric compound that binds to bile acid and helps it be eliminated from the body. Cholestyramine is not soluble in water, but it is very good at absorbing liquids.
Cholestyramine Lightis the brand name
image of different drug pills on a surface
Questran Light Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Cholestyramine Light
Cholestyramine
1994
47

Approved as Treatment by the FDA

Cholestyramine, commonly known as Cholestyramine Light, is approved by the FDA for 5 uses like Hardening of the Arteries and Primary Hypercholesterolemia .
Hardening of the Arteries
Helps manage Atherosclerosis
Primary Hypercholesterolemia
partial biliary obstruction
Itching
Pruritus

Effectiveness

How Questran Light Affects PatientsCholesterol is needed to create bile acids, which help with digestion. Normally, bile acids are secreted into the intestines and absorbed back into the liver. Cholestyramine resin binds with the bile acids in the intestines, forming an insoluble complex that gets passed out in the feces. This helps to prevent the bile acids from being reabsorbed and thus lowers their levels in the body.
How Questran Light works in the bodyCholestyramine is a medication that helps reduce the reabsorption of bile acids in the digestive tract. It works by sticking to anionic bile acids and forming a strong resin matrix. This creates an exchange of chloride anions with the bile acid particles. The medication is made up of a quaternary ammonium group attached to an inert styrene-divinylbenzene copolymer.

When to interrupt dosage

The measure of Questran Light rests on the diagnosed condition, such as Hardening of the arteries, Itch and Primary Hypercholesterolemia. The portion likewise changes in accordance with the mode of delivery (e.g. Oral or Powder, for suspension) given in the table beneath.
Condition
Dosage
Administration
Itching
, 4.0 mg/mg, 4000.0 mg, 1000.0 mg, 400000.0 mg, 4000.0 mg/dose
, Oral, Powder, for suspension, Powder, for suspension - Oral, Powder, for solution, Powder, for solution - Oral, Tablet, Tablet - Oral, Kit; Powder - Oral, Kit; Powder, Powder, Powder - Oral, Powder; Suspension - Oral, Powder; Suspension
Hardening of the Arteries
, 4.0 mg/mg, 4000.0 mg, 1000.0 mg, 400000.0 mg, 4000.0 mg/dose
, Oral, Powder, for suspension, Powder, for suspension - Oral, Powder, for solution, Powder, for solution - Oral, Tablet, Tablet - Oral, Kit; Powder - Oral, Kit; Powder, Powder, Powder - Oral, Powder; Suspension - Oral, Powder; Suspension
partial biliary obstruction
, 4.0 mg/mg, 4000.0 mg, 1000.0 mg, 400000.0 mg, 4000.0 mg/dose
, Oral, Powder, for suspension, Powder, for suspension - Oral, Powder, for solution, Powder, for solution - Oral, Tablet, Tablet - Oral, Kit; Powder - Oral, Kit; Powder, Powder, Powder - Oral, Powder; Suspension - Oral, Powder; Suspension
Primary Hypercholesterolemia
, 4.0 mg/mg, 4000.0 mg, 1000.0 mg, 400000.0 mg, 4000.0 mg/dose
, Oral, Powder, for suspension, Powder, for suspension - Oral, Powder, for solution, Powder, for solution - Oral, Tablet, Tablet - Oral, Kit; Powder - Oral, Kit; Powder, Powder, Powder - Oral, Powder; Suspension - Oral, Powder; Suspension

Warnings

Questran Light Contraindications
Condition
Risk Level
Notes
complete biliary obstruction
Do Not Combine
There are 20 known major drug interactions with Questran Light.
Common Questran Light Drug Interactions
Drug Name
Risk Level
Description
Mycophenolate mofetil
Major
Cholestyramine may increase the excretion rate of Mycophenolate mofetil which could result in a lower serum level and potentially a reduction in efficacy.
Mycophenolic acid
Major
Cholestyramine may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.
Raloxifene
Major
Cholestyramine can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.
(R)-warfarin
Minor
Cholestyramine can cause a decrease in the absorption of (R)-warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.
(S)-Warfarin
Minor
Cholestyramine can cause a decrease in the absorption of (S)-Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Questran Light Toxicity & Overdose RiskOverdosing on the drug may lead to an obstruction in the stomach or intestines.
image of a doctor in a lab doing drug, clinical research

Questran Light Novel Uses: Which Conditions Have a Clinical Trial Featuring Questran Light?

68 active studies are in progress to assess the potential of Questran Light to ameliorate Itch, partial biliary obstruction, and Primary Hypercholesterolemia.
Condition
Clinical Trials
Trial Phases
Primary Hypercholesterolemia
8 Actively Recruiting
Phase 3, Phase 2, Not Applicable
Itching
2 Actively Recruiting
Phase 3, Not Applicable
partial biliary obstruction
0 Actively Recruiting
Hardening of the Arteries
18 Actively Recruiting
Not Applicable, Phase 4, Phase 2, Phase 3

Questran Light Reviews: What are patients saying about Questran Light?

5Patient Review
4/7/2015
Questran Light for Chronic Diarrhea
This medication has been a life-saver. I was struggling with severe diarrhea and couldn't leave the house without constant worry. After just six months of taking one sachet per day, I no longer have any issues.
5Patient Review
5/25/2012
Questran Light for Chronic Diarrhea
I've been struggling with chronic diarrhea for six years now, and this medication has finally allowed me to have some semblance of a normal life again. I can't thank Questran enough!
5Patient Review
2/22/2008
Questran Light for Chronic Diarrhea
4.7Patient Review
1/19/2019
Questran Light for Chronic Diarrhea
Questtan Lite has been a godsend for my Lymphocytic Colitis. I was on steroids for two months prior, but I was still having to use the restroom several times per day. Since starting this medication, though, that urgency has gone away and I've had fewer trips to the bathroom overall.
4.7Patient Review
10/26/2009
Questran Light for Chronic Diarrhea
Questran Light has been fantastic for me since having my gallbladder removed. It's completely stopped the chronic diarrhea I was experiencing. The only downside is the powdery texture, which makes it a bit difficult to take.
4.7Patient Review
6/20/2009
Questran Light for Chronic Diarrhea
I wish this were available in pill form. The daily dose is tough to consume otherwise.
4.7Patient Review
11/15/2009
Questran Light for Chronic Diarrhea
I'd been dealing with IBS for years by the time I saw a specialist in my senior year of high school. They prescribed me this medication, and it worked immediately. That was nine years ago, and I haven't had a single problem since. But now my doctor wants me to stop taking it before I try to get pregnant, and I'm honestly terrified that something will go wrong if I do. This drug has been a miracle for me, and I don't know if I can live without it.
4.7Patient Review
2/22/2011
Questran Light for Chronic Diarrhea
The taste isn't great, but it's not terrible either. It's more of a gritty texture that turns my stomach.
4Patient Review
10/6/2014
Questran Light for Chronic Diarrhea
After my intestinal surgery for Crohn's, this medication really helped to control my diarrhea.
3.3Patient Review
2/26/2009
Questran Light for Chronic Diarrhea
Questran Light was recommended to me by my doctor, and it has been an absolute godsend. If you suffer from chronic diarrhea, I urge you to give this medication a try.
3.3Patient Review
10/16/2018
Questran Light for Chronic Diarrhea
My stomach nerves were damaged during a hernia surgery, and ever since then I've had diarrhea 2-3 times per week. After taking Questran Lite for two weeks, I experienced perfect results; however, those good results have diminished over the past 6 weeks until now where I'm back at having dumping 2-3 times per week. Does anyone have any suggestions?
3Patient Review
1/11/2011
Questran Light for High Cholesterol
This medicine has been a godsend for me. I was originally misdiagnosed with IBS, but recently learned that I have Habba Syndrome, which is similar but caused by the overproduction of bile. This medication stops the reabsorption of bile and has completely alleviated my symptoms! The only downside is that the powder is very bitter and unpleasant to drink (even in Gatorade).
3Patient Review
7/16/2021
Questran Light for Chronic Diarrhea
I've only just started taking this medication and experienced terrible stomach pain on the first day. However, I will persevere as I suffer from chronic diarrhea which can have me running to the bathroom up to 20 times a day. I'm also very sensitive to food and medications, so I'll keep trying this treatment and let you know how it goes.
2.7Patient Review
6/14/2022
Questran Light for chronic diarrhea due to bile acid malabsorption
I've had to take this powder for years due to bile acid malabsorption, and it's incredibly unpleasant. It does help with the diarrhoea, but I feel like I can't stand to take it another day. I've heard there's a pill available in the UK called Colesevelam that has the same effect, but it's not available in Australia. I hope there's some way I can get my hands on it because Questran is absolutely terrible.
2.7Patient Review
2/19/2011
Questran Light for Chronic Diarrhea
I'm not sure if this will help me or not, but for those who want a pill form of the treatment, Welchol is available. I tried it last May for my hyperlipidemia and had to take six pills a day, which made me nauseous.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about questran light

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Questran Light used for?

"This medicine helps to lower your body's cholesterol levels, which can reduce your risk of heart disease. It works by adsorbing bile acids containing cholesterol in the digestive system, which are then eliminated from the body in the faeces."

Answered by AI

What are the side effects of Questran Lite?

"The following effects may occur: constipation, stomach/abdominal pain, gas, nausea, or vomiting. If you experience any of these effects, tell your doctor or pharmacist."

Answered by AI

When should I take Questran?

"This medication is to be taken as prescribed by your doctor. The medication should be taken before a meal and/or at bedtime. Any other medications should be taken at least 1 hour before or 4 hours after you take cholestyramine to avoid interference with absorption."

Answered by AI

Is there an alternative to Questran Light?

"If questran & colesevelam are not available from your local pharmacies, colestipol granules (Brand name Cholestid) is the only alternative bile acid sequestrant available."

Answered by AI

Clinical Trials for Questran Light

Image of Wake Forest University Health Sciences in Winston-Salem, United States.

Statins + Lifestyle Counseling for High Cholesterol

40 - 75
All Sexes
Winston-Salem, NC
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders (EMERALD) is a protocolized intervention based on American College of Cardiology/American Heart Association and US Preventive Services Task Force guidelines designed to initiate preventive cardiovascular care for emergency department patients being evaluated for acute coronary syndrome. The overarching goals of this proposal are to (1) determine the efficacy of EMERALD at lowering low-density lipoprotein cholesterol (LDL-C) and non high-density lipoprotein cholesterol (non-HDL-C) among at-risk Emergency Department (ED) patients who are not already receiving guideline-directed outpatient preventive care and (2) inform our understanding of patient adherence and determinants of implementation for ED-based cardiovascular disease prevention strategies.
Phase 2
Recruiting
Wake Forest University Health SciencesNick Ashburn
Have you considered Questran Light clinical trials? We made a collection of clinical trials featuring Questran Light, we think they might fit your search criteria.Go to Trials
Image of University of Pennsylvania, Perelman School of Medicine in Philadelphia, United States.

Cascade Screening for High Cholesterol

18+
All Sexes
Philadelphia, PA
The goal of this clinical trial is to test two implementation strategies (automated health system \[Penn Medicine\]-mediated strategy vs. Family Heart Foundation-mediated strategy using a patient navigator) versus usual care to promote family cascade screening for familial hypercholesterolemia (FH) in Penn Medicine patients diagnosed with FH ("probands"). The main questions this study aims to answer are: (1) evaluating the effect of the three approaches on reach (proportion of probands who have at least one family member who completes screening), number of family members screened, number of family members diagnosed with FH, and proband LDL-C levels; and (2) identifying implementation strategy mechanisms focusing on health equity using mixed methods and oversampling populations that experience disparities. Participants (probands) in the active arms (health system \[Penn Medicine\]-mediated, Family Heart Foundation-mediated) will receive messaging that provides education about FH and provides instructions for participating in family cascade screening. A subset of probands will be invited to complete a qualitative interview about their experience receiving the implementation strategy. The research team will compare the active arms to Penn Medicine usual care for cascade screening to evaluate whether the active arms are more effective at promoting cascade screening than usual care.
Waitlist Available
Has No Placebo
University of Pennsylvania, Perelman School of Medicine
Have you considered Questran Light clinical trials? We made a collection of clinical trials featuring Questran Light, we think they might fit your search criteria.Go to Trials
Image of Washington University School of Medicine in Saint Louis, United States.

Meal Intake for Atherosclerosis

18 - 95
All Sexes
Saint Louis, MO
High protein low carbohydrate diets have become popular in recent years to help facilitate weight loss. It is controversial if these diets are associated with an increased risk of cardiovascular disease. Recent work in mice has implicated monocytes/macrophages and mTOR signaling as the culprit cell type driving the increased cardiovascular risk with high protein diets. We aim to build on this preclinical research by evaluating the effects of liquid meals with different protein and leucine (a potent mTOR activator) contents on circulating human monocytes and platelets. Study participants will be given either a low protein liquid meal, a high protein liquid meal, or a low protein liquid meal with additional leucine. Blood will be collected from study participants just just prior to and for several hours after ingestion of the meals. Activation of amino acid-dependent signaling pathways (particularly mTOR) and downstream sequelae will be evaluated in the isolated monocytes and platelets.
Waitlist Available
Has No Placebo
Washington University School of Medicine (+2 Sites)Bettina Mittendorfer
Image of University of Maryland Amish Research Clinic in Lancaster, United States.

Direct Contact Genetic Screening for High Cholesterol

18+
All Sexes
Lancaster, PA
An important aspect of successful genomic medicine implementation is developing effective approaches for screening at-risk family members after probands are identified, also known as cascade screening. Most cascade screening studies conducted to date have been conducted outside the US, and very few studies have used a rigorous approach involving a comparator group or randomized controlled design. A major question in the field is how to most effectively implement cascade screening, given commonly cited communication barriers, while respecting privacy among probands and family members. This study will conduct a randomized controlled trial to assess direct contact of relatives by study team members vs indirect, or proband-initiated, contact. We will assess efficacy of the cascade screening intervention, patient-centered outcomes regarding mental, physical, and psychosocial outcomes in probands and family members, and implementation evaluation outcomes. Individuals who are known to carry the KCNQ1 Met224Thr or APOB Arg3527Gln variant will be eligible to participate. After providing consent and being deemed eligible, individuals will be randomized in a 1:1 manner into the direct or indirect contact of family members arm of the study. The randomization will be stratified by variant to ensure equal representation of each variant in the study arms. Individuals in the indirect arm will be instructed to contact their first-degree family members about the opportunity to be screened. They will be provided with a disease-specific pamphlet and a family letter explaining the cascade screening. In the direct arm, probands will be advised that the study staff will be contacting their family members. They will be instructed to also contact their family members prior to the study team contacting them. Approximately two weeks after this meeting with the proband, the study staff will mail letters to eligible first-degree family members of the probands. If we do not hear back from individual family members, we will follow-up with another letter, telephone call, or home visit. The information contained in the letters will be the same information for both the direct and indirect arms of the study. All interested family members will receive pre-test counseling and free, in-home, saliva-based genetic testing, and post-test counseling.
Recruiting
Has No Placebo
University of Maryland Amish Research Clinic
Have you considered Questran Light clinical trials? We made a collection of clinical trials featuring Questran Light, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security